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Summary Staphylococcus aureus is a major cause of nosocomial infections and a risk in patients who have either
undergone surgery or are on haemodialysis. The S. aureus infections in patients admitted to the clinical
departments of Al-Makased Charitable Hospital in Jerusalem during a period of one year were investigated.
Isolates included were from blood, surgical wounds, or other nonsuperficial sites. Of 63 isolates available for
analysis, 46 (73.0%) expressed type 8 capsular polysaccharide; 13 (20.7%), type 5 capsular polysaccharide;
only 4 isolates (6.3%) did not express type 5 or type 8 antibodies. The strains fitted in 7 different antibiogram
types, with the type showing resistance only to penicillin and ampicillin prevalent in 34 out of 63 isolates
(54.0%). Of the 12 methicillin-resistant S. aureus (MRSA) isolates (19.1%), 8(66.7%) possessed the type 8
capsule and 4(33.7%) the type 5 capsule. Pulsed-field gel electrophoresis of all isolates with the restriction-
endonuclease enzymes Sma I revealed 34 patterns demonstrating that no single methicillin-sensitive S. aureus
strain was endemic in the hospital. However, all MRSA isolates with a type 8 capsule showed identical PFGE
patterns using the 2 restriction-endonuclease enzymes Sma I and SST II. Moreover, type 5 isolates showed
identical patterns (one isolate differed from the rest with one band only). These data suggest and confirm the
clonality of type 5 and type 8 MRSA isolates. Analysing the results of the capsular and antibiogram typing
schemes in conjunction proved useful and suggested that such an analysis can be employed as a helpful
epidemiological tool in hospitals with limited resources.
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Introduction
Staphylococcus aureus, a major cause of hospital-acquired
infections, causes serious systemic infections including
bacteraemia, endocarditis and osteomyelitis. Virtually all
nosocomial strains of S. aureus produce at least one of a
group of enzymes known as the beta-lactamases which render
the organisms resistant to penicillin and/or other b–lactam
antibiotics. These infections have been associated with
outbreaks caused by multidrug resistant strains of S. aureus,
mainly by methicillin-resistant S. aureus (MRSA) (Musher &
McKenizie 1977; Bennet & Hall 1988; Weinstein 1991).
MRSA strains were first isolated in England after the
introduction of semisynthetic penicillins in 1959. Their
spread was soon noted in the United States and across the
world (Anonymous 1961; Lacey 1987). Reports of MRSA
outbreaks in tertiary hospitals, community teaching
hospitals, nursing homes and rehabilitation facilities (CDC
1981; McGowan 1988; Storch et al. 1990) soon followed.
The outburst of infections caused by MRSA created
obstacles for physicians and infection control personnel in
health care centres around the world. The main problem was
failure of treatment due to the multiple resistance of these S.
aureus strains. Patients acquiring an infection caused by
MRSA are usually treated with vancomycin, a toxic and
relatively expensive antibiotic. It is, however, feared that other
gram-positive cocci groups, which have developed
vancomycin resistance such as the enterococci (Uttley et al.
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Diagnostics, Ontario, Canada) for further analysis at NABI,
Rockville, USA.
Capsular polysaccharide typing
Capsular serotyping of the isolates was performed by direct
cell agglutination and immuno-precipitation of cell extracts.
The organisms were grown at 378C under 5% CO2 on
Columbia broth (Difco Laboratories, Detroit, Michigan)
supplemented with 1.5% CaCl2 and 0.5% MgCl2. Samples
were removed from the flasks and tested for capsulation as
follows: rabbit antiteichoic acid sera, prepared with the
noncapsulated Wood strain (Karakawa et al. 1985), were
diluted with saline to 1/512 to give lower titre preparations.
Samples were tested for direct agglutination with the different
preparations. Cultures which did not show agglutination at a
titre of , 1:4 of the original sera were considered fully
capsulated and could be tested for capsular typing. Two
different rabbit sera were used in the direct agglutination
assay to identify the capsular type of each isolate: sera from
animals vaccinated with a whole cell vaccine (Karakawa et al.
1985), and sera prepared in rabbits against either type 5 or
type 8 conjugated vaccine (Fattom et al. 1990, 1993).
Monoclonal antibodies to capsular types 5 and 8 produced
and standardized by Nabi (Rockville, Maryland) were used to
confirm the capsular serotype of the isolates.
Antimicrobial susceptibility testing
The susceptibility of all isolates to different antimicrobials
was tested by the disk-agar diffusion method in accordance
with the National Committee for Clinical Laboratory
Standards (NCCLS 1993). The antimicrobial disks used were
tetracycline (30 mg/ml), oxacillin (1 mg/ml), penicillin
(10 U/ml), erythromycin (15 mg/ml), ampicillin (10 mg/ml),
vancomycin (30 mg/ml), clindamycin (2 mg/ml), cephalothin
(30 mg/ml) and gentamicin (10 mg/ml) (Becton Dickinson
Microbiology system, BBL, Cockeysville, MD). The results of
these tests were recorded after 18–24 h of incubation at
35 8C. A standard strain of S. aureus (ATCC 25923) was used
as a control.
Detection of MRSA
Two standard methods were used for the detection of MRSA.
The disk agar diffusion method using a 1 mg oxacillin disk
incubated at 35 8C for 24 h and checking after 48 h (NCCLS
1993), and ability to grow on Mueller-Hinton agar
supplemented with 4% NaCl, and 6 mg/ml of oxacillin
(MRSA screen agar, BBL, Cockeysville, MD) after incubation
at 35 8C for 24 h (McDougal & Thornsberry 1984; Working
Party 1986).
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1989; Al Obeid et al. 1990), may transmit the gene(s)
responsible for this property to S. aureus, leaving few, if any,
options for antimicrobial chemotherapy (Schwalbe et al.
1987). In fact, S. aureus isolates which exhibit an increased
resistance to vancomycin have been reported in the USA and
Japan (CDC 1997a,b).
Epidemiologically, MRSA is introduced to hospital settings
through different routes, most commonly through a patient
infected with MRSA who then serves as a singular S. aureus
infection reservoir (Colley et al. 1965; Peacock et al. 1980).
Cross-infection involving hospital staff is another mode of
transmission (Ward et al. 1981). Due to the difficulties created
by the inability to control the spread of the organism in an
outbreak and to treat the patients infected by it, efforts must
be made to detect MRSA eruption early and to promptly
implement infection control measures that may limit the
consequences of a flare-up (Boyce et al. 1981; McManus et al.
1989; Mulligan & Arbeit 1991). Proper monitoring of
hospitals for emergence of S. aureus (and MRSA) infections
may occur only if extensive epidemiological studies are
performed.
Reports about the occurrence and prevalence of infections
caused by S. aureus including MRSA in hospitals in Palestine
were practically nonexistent. We chose Al-Makased Hospital,
the largest and best equipped hospital in East Jerusalem,
which serves as a reference hospital for patients suffering
from profound medical conditions, for our study. The
objectives were surveillance of S. aureus infections,
determination of the prevalence of MRSA in infection
isolates in hospital wards, and phenotypic as well as
genotypic characterization of S. aureus isolates.
Materials and methods
Study isolates
Sixty-three S. aureus isolates were recovered from clinical
specimens submitted to the clinical microbiology laboratory
of Al-Makased Hospital between November 1993 and
November 1994. They included blood and pus from
nonobvious pyogenic infections that occurred in patients
admitted to different hospital departments. In some cases,
multiple isolates from one patient were tested and invariably
found identical. Therefore one isolate was used for inclusion
in the study in these cases. Specimens were registered and
processed and the isolated pathogens were identified by
standard procedures (Kloos & Lambe 1991). The S. aureus
isolates retrieved were sent to the research laboratory (NABI
– Rockville), on blood agar plates (BBL, Cockeysville, MD),
where their identity was reconfirmed using standard
procedures (Kloos & Lambe 1991). The isolates were then
stored at 270 8C in microbank ampules (Pro-Lab
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b—lactamase production test
The ability of the isolates to produce b–lactamase was tested
by using several similar colonies from a fresh culture to smear
disks impregnated with the chromogenic cephalosporin,
nitrocephin (cefinase disks BBL, Cockeysville, MD). A
positive result was recorded upon the development of a
yellow to dark red colour change, within a period of one
hour, on the area where the culture was applied.
Confirmatory tests were performed by the disk agar diffusion
method using amoxicillin clavulanic acid (AMC30) and
ampicillin-sulbactam (SAM20) disks (Difco laboratories,
Detroit, MI) as recommended (NCCLS 1993).
Genomic DNA analysis by pulsed field gel electrophoresis
(PFGE)
S. aureus genomic DNA was extracted from overnight agar
cultures inoculated (initial O. D.540 5 0.1) into 10 ml of brain
heart infusion broth (BBL, Cockeysville, MD.) and incubated
with shaking at 37 8C to a final O. D.540 5 1.0 as described by
Murray et al. (1990) and modified by Wanger et al. (1992).
The DNA size standards used were a bacteriophage lambda
ladder consisting of concatemers starting at 48.5 kbp and
increasing to approximately 1000 kbp (Bio-Rad Laboratories,
Hercules, CA). The gels were stained with ethidium bromide,
rinsed and photographed under UV light.
Results
Hospital source and capsular typing of the isolates
Sixty-three clinical S. aureus isolates from the different
clinical departments of Al-Makased Hospital in Jerusalem
were sent to the research laboratory during the period
November 1993 to November 1994. The infected patients
were distributed in the different hospital departments as
follows: 28 in orthopaedics and general surgery, 18 in
paediatrics and neonatology, 10 in internal medicine, 4 in the
surgical intensive care unit and 3 in obstetrics. Table 1 shows
the capsular types of the S. aureus isolates obtained from
each hospital department. Type 8 isolates were predominant
as they constituted 73% (46/63) of all isolates with type 5
noted in 20.7% (13/63) of the isolates. The remaining 4
isolates (6.3%) were not typed by the type 5 or the type 8
antisera. Most isolates (93.%) were typed as either having the
type 5 or the type 8 capsule; however, isolates with the type 8
capsule predominated over other types in all hospital
departments.
Antibiogram typing
The antibiotic susceptibility of the 63 isolates was tested by
disc-agar diffusion method. Table 2 shows the antibiogram
types and Table 3 indicates that the majority of the isolates
(34/63; 54%) were of antibiogram type F, i.e. resistant only to
penicillin and ampicillin. Antibiogram F isolates were
recovered from all the clinical departments of our hospital
except the surgical ICU. The multiresistant strains belonging
to type A, sensitive only to vancomycin, were mainly isolated
Table 1 Capsular types of the Staphylococcus aureus clinical
isolates from patients at Al-Makased hospital as stratified by hospital
source
Capsular type
Hospital department T5 T8 N* Total
Surgical ICU 0 3 1 4
Internal medicine 3 6 1 10
Neonatology 1 9 0 10
Obstetrics 0 2 1 3
Paediatrics 1 6 1 8
Orthopedic surgery 5 13 0 18
General surgery 3 7 0 10
Total 13 46 4 63
*Non 5 or 8 capsular type.
Type Tet Ox P E Am Va Cc Cf Gm
A r r r r r s r r r
B r r r r r s s r r
C r s r r r s s s s
D r s r s r s s s s
E s s r r r s s s s
F s s r s r s s s s
G s s s s s s s s s
Abbreviations: Tet, tetracycline; Ox, oxacillin; P, penicillin G; E, erythromycin; Am, ampicillin;
Va, vancomycin; Cc, clindamycin; Cf, cephalothin; Gm, gentamicin; s, susceptible; r, resistant.
Table 2 Staphylococcus aureus antibiogram
types identified at Al-Makased Hospital
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from two adjacent wards: neonatology and paediatrics (7/11;
63.6%). The 4 other multiresistant isolates were recovered
from two other adjacent wards: orthopaedic and general
surgery. Antibiogram type D, of strains resistant to
ampicillin, penicillin and tetracycline, was as prevalent in the
clinical isolates as was the multiresistant antibiogram A.
Antibiogram type G isolates, susceptible to all antimicrobials
tested, including penicillin, were not common and appeared
only in 2 (3.2%) isolates. Table 4 lists the distribution of the
S. aureus isolates by capsular and antibiogram types. The
biggest cluster of strains is the one showing the capsular type
8 and antibiogram type F, constituting 44.4% (28/63).The
multiresistant strains in antibiogram type A more commonly
(63.6%) possessed the type 8 capsule.
Methicillin-resistant infection isolates
The numbers of MRSA (antibiograms A and B) isolated from
the different hospital locations are given in Table 5. Of the 12
(19.1%) isolates identified as MRSA, 66.7% (8/12) possessed
a type 8 capsule, while the remaining 4 (33.3%) had a type 5
capsule. Table 5 also shows that, unlike the type 8 MRSA
strains which were isolated at different intervals during our
study and from most of our hospital departments, type 5
MRSA appeared within a specific period (2/94 and 3/94) and
in only two adjacent wards of the orthopaedic and general
surgery departments.
Pulse field gel electrophoresis
To investigate the relatedness of the isolates genotypically,
PFGE of all isolates was performed using the restriction-
endonuclease enzyme Sma I. Thirty-four distinct patterns
without significant clustering were recovered, suggesting 
lack of clonal relatedness among the isolates included in 
the study. However, different results were obtained when 
the 12 MRSA isolates were analysed distinctly. On 
Antibiogram type
———————————————————————–
Department A B C D E F G Total
Surgical ICU 0 0 1 3 0 0 0 4
Internal medicine 0 1 1 2 0 6 0 10
Neonatology 5 0 0 0 1 4 0 10
Obstetrics 0 0 0 0 0 3 0 3
Paediatrics 2 0 1 1 0 3 1 8
Orthopedic surgery 3 0 0 1 0 13 1 18
General surgery 1 0 0 4 0 5 0 10
Total 11 1 3 11 1 34 2 63
Capsular Antibiogram type
————————————————————————————–
Type A B C D E F G Total
5 4 0 2 2 1 4 0 13
8 7 1 1 8 0 28 1 46
N 0 0 0 1 0 2 1 4
Total 11 1 3 11 1 34 2 63
Table 3 Antibiogram types of the
Staphylococcus aureus isolates retrieved from
the different hospital departments
Table 4 Staphylococcus aureus isolates
included in the study distributed by capsular
and antibiogram type
Table 5 The 12 methicillin-resistant Staphylococcus aureus isolates
as stratified by hospital source, date of isolation and capsular type
Hospital Date of Type Anti- Type
department isolation 5 biogram 8
Neonatology 11/93 0 A,A 2
1/94 0 A,A 2
2/94 0 A 1
Paediatrics 11/93 0 A 1
11/94 0 A 1
Orthopedic Surgery 2/94 2 A,A 0
3/94 1 A 0
General Surgery 3/94 1 A 0
Internal Medicine 12/93 0 B 1
Total 4 8
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digestion with Sma I, all isolates with type 8 capsules 
showed similar patterns (Figure 1). The isolates with type 5
capsules, however, showed two similar DNA banding
patterns, with three of the capsular type 5 isolates having
identical DNA patterns and the fourth having one different
band (data not shown). The type 8 isolates had identical
patterns to that obtained from a nasal isolate from an
attending nurse.
Discussion
Serious S. aureus infections in hospitalized patients are
caused by auto-inoculation from a common carriage site,
usually the anterior nares, or by transfer from another carrier
such as a patient or health care worker. Health care workers
were often implicated as a potential reservoir for nosocomial
outbreaks of MRSA (Na’was & Fakhoury 1991; Scully et al.
1992), a dangerous organism that causes hospital outbreaks
which are difficult to control, costly, and very dangerous to
high risk patients (Lamb 1991).
Most of the S. aureus clinical isolates possessed capsular
polysaccharides of multiple distinct serological types. Since
their discovery and the establishment of the capsular typing
scheme (Arbeit et al. 1984; Karakawa et al. 1985), numerous
studies have used the new scheme for the typing of infectious
isolates of man and animals. Of the 13 known capsular types,
types 5 and 8 comprise the majority of all clinical isolates
from man, sheep, cows, poultry and other animals (Poutrel
et al.1993; Daum et al. 1994), thus limiting the usefulness of
the capsular polysaccharide typing scheme as an
epidemiological tool to identify outbreaks in hospitals and to
establish relatedness of isolates.
Advances in molecular biology and the subsequent
introduction and widespread use of more sophisticated
methodologies such as PFGE, which discriminates isolates
based on their genetic profile, have diverted attention away
from the development and potential utility of other simple
typing schemes such as capsular polysaccharide and
antibiogram typing. As a result, medical microbiology
laboratories in developing countries, where resources are
limited, have been further limited to play a role in the effort
to properly detect epidemics involving S. aureus and to
develop appropriate and cost-effective infection control
measures. In certain countries antibiotics are freely dispensed
over the counter (OTC) and hospitals lack policies regarding
their use. Due to these problems, establishing a simple and
accurate tool for the detection of MRSA outbreaks has
become essential to effective infection control in these
countries.
For the first time in the Al-Makased hospital in Jerusalem,
the capsular polysaccharide serotyping scheme was used to
investigate the distribution of capsular types among the S.
aureus clinical isolates from patients in all hospital
departments. The majority of isolates (93.7%), were, as
expected, capsulated by either a type 5 or a type 8 capsule,
with obvious prevalence of type 8 (73.0%).
Figure 1 CHEF Characterization of MRSA
isolates by pulsed-field gel electrophoresis.
Chromosomal DNA was digested with
endonuclease Sma I (lanes 2–10) and
separated by pulsed-field gel electrophoresis
apparatus then photographed under UV
light. The 7 similar patterns shown (lanes
2–8) represent the type 8 isolates, while lane
10 represents a nasal isolate from an
attending nurse. Lane 1 contains size
markers.
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The only isolate we were able to obtain from these nasal
MRSA isolates was from a nurse in the paediatric ward. The
strain was a type 8 isolate that gave an identical PFGE profile
to the infection (outbreak) isolates with the same capsular
type, thus proving our theory concerning the source of the
MRSA strains in our hospital, and supporting published data
(Sewell et al. 1982; Yu et al. 1986; Casewell & Hill 1986) for
other hospitals. Moreover, the abscence of MRSA infections
in the hospital following the treatment of S. aureus carriers
with antibiotics and consequently their clearance strongly
suggest the role of nasal carriage among medical personnel in
dissimination of S. aureus infection in hospitalized patients.
The data presented in this paper confirms the value of
using capsular typing in conjunction with antibiogram typing
as a simple, cheap, and efficient strategy in pin-pointing
epidemics or outbreaks caused by multiresistant S. aureus
strains in hospitals. Moreover, the combined method may
serve as a convenient and cheap way for periodic monitoring
of nasal carriers and identification of the main reservoirs of
MRSA in hospitals, in order to control the spread of these
dangerous organisms.
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